Caliph Pharmaceuticals (Pvt) Ltd.
Pharmaceutical company · 202 brands · 190 molecules
Ranked #14 of 178 companies in Antiinflammatory And Antirheumatic Products
Company overview
Caliph Pharmaceuticals (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 202 product registrations across 190 distinct molecules. It is the 73rd largest registrant in Pakistan by product count, and ranks 14th of 178 in Antiinflammatory And Antirheumatic Products. Its portfolio is concentrated in Antiinflammatory And Antirheumatic Products and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). DRAP has issued 2 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by Caliph
80 products matched in our catalogue — each with its observed price and DRAP approved ceiling.
Price ceiling age
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
Top molecules by brand count
Therapeutic classes
Conditions treated
Price band (DRAP official ceilings)
Regulatory record
2 alerts in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Portfolio whitespace
Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.
Get the full profile for Caliph
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included